[HTML][HTML] Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation

BR Jin, HJ Kim, JH Na, WK Lee, HJ An - Journal of Advanced Research, 2024 - Elsevier
Abstract Introduction Apocynin (Apo), an NADPH oxidase (NOX) inhibitor, has been widely
used to treat various inflammatory diseases. However, the therapeutic effects of Apo on …

Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.

BR Jin, HJ Kim, JH Na, WK Lee… - Journal of Advanced …, 2023 - europepmc.org
Objectives The link between androgen signaling, reactive oxygen species (ROS), and
prostate cell proliferation may contribute to the pathogenesis of BPH; therefore, the aim of …

Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation

BR Jin, HJ Kim, JH Na, WK Lee… - Journal of advanced …, 2024 - pubmed.ncbi.nlm.nih.gov
Introduction Apocynin (Apo), an NADPH oxidase (NOX) inhibitor, has been widely used to
treat various inflammatory diseases. However, the therapeutic effects of Apo on benign …

Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation

BR Jin, HJ Kim, JH Na, WK Lee… - Journal of Advanced …, 2024 - khu.elsevierpure.com
Abstract Introduction: Apocynin (Apo), an NADPH oxidase (NOX) inhibitor, has been widely
used to treat various inflammatory diseases. However, the therapeutic effects of Apo on …

[HTML][HTML] Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation

BR Jin, HJ Kim, JH Na, WK Lee… - Journal of Advanced …, 2024 - ncbi.nlm.nih.gov
Objectives The link between androgen signaling, reactive oxygen species (ROS), and
prostate cell proliferation may contribute to the pathogenesis of BPH; therefore, the aim of …

Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.

BR Jin, HJ Kim, JH Na, WK Lee… - Journal of Advanced …, 2023 - europepmc.org
Apocynin (Apo), an NADPH oxidase (NOX) inhibitor, has been widely used to treat various
inflammatory diseases. However, the therapeutic effects of Apo on benign prostatic …